We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.00 | -0.12% | 1,703.00 | 1,703.00 | 1,704.00 | 1,711.00 | 1,695.50 | 1,705.00 | 189,062 | 08:16:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.24 | 70.2B |
Date | Subject | Author | Discuss |
---|---|---|---|
28/4/2020 08:55 | Probably tomorrow profit taking, always seem to be over 1700p. | montyhedge | |
28/4/2020 08:15 | Expect a lowering of targets. On Feb. 5, GlaxoSmithKline reported fourth-quarter 2019 earnings that fell short of analysts' expectations. Pricing pressure, mainly hitting its respiratory drugs, contributed to the shortfall. The company was then forecasting 2020 adjusted profit to be down as much as 4%. And that was before the virus. | tradermichael | |
27/4/2020 21:15 | company reward scheme acquisition. We may find out on Wednesday if she is worthy of the reward :-) | sicker | |
27/4/2020 21:07 | Sorry - re read it. 2407 shares | watfordhornet | |
27/4/2020 20:57 | Did Emma Walmsley buy 2.4m shares on 14th April? | watfordhornet | |
27/4/2020 17:41 | And the next day interesting for GSK :-) | sicker | |
27/4/2020 17:28 | No BP, tomorrow will be interesting for BP. | montyhedge | |
27/4/2020 15:20 | No BP then monty ? | sicker | |
27/4/2020 14:40 | Dividend I mean. | montyhedge | |
27/4/2020 14:40 | GSK and AstraZeneca safest in the FTSE 100 in my view. | montyhedge | |
27/4/2020 10:28 | 2 1/2 weeks to the next ex. div (Thursday 14 May). Critical that the dividend is maintained ……. | tradermichael | |
27/4/2020 09:24 | Beckers, I shouldn't think there's been much of a supply impact for GSK so far (the pharmaceutical supply network is usually more robust than 2 months). However, there may be an indication announced for the next quarter. Also, the firm may produce some 'creative accounting' on the back of the Covid situation to offset what was going to be a negative performing year anyway. | tradermichael | |
25/4/2020 16:29 | TM 'Let's get through the Q1 results first! (Wed 29 April)' Do you expect that GSK could reveal some costs or supply shortages in connection with Covid-19? | beckers2008 | |
24/4/2020 16:44 | Even at £25 some would not be happy! | rikky72 | |
24/4/2020 14:43 | Not bothered about price as I bought for income. Would prefer to see a progressive dividend policy tbh. spud | spud | |
24/4/2020 14:26 | OK £17 next week, £18 next month and £25 by August everyone happy!!! | robbiekeane | |
24/4/2020 09:22 | Let's get through the Q1 results first! (Wed 29 April) | tradermichael | |
24/4/2020 08:50 | Lets not get ahead of ourselves. Just hope to hit £18 in the next month. | cyfalafwr | |
23/4/2020 16:45 | Whatever is required to test / treat or beat covid will be signed off by the government. They are throwing money at drug companies to facilitate the search for a cure. GSK is doing it's bit by entering collaborations but hospital spend at the moment is waved through which will benefit pharma's. | robbiekeane | |
23/4/2020 14:54 | NHS what blank cheque? | abdullla | |
23/4/2020 14:37 | NHS Covid19 blank cheque could see this rise to £25 great defensive stock. | robbiekeane | |
17/4/2020 16:19 | Since 24 Feb when the market started its dramatic downturn due to the coronavirus fallout, GSK has faired well IMO. It was around 16% down at its worst, whereas the FTSE 100 was around 32% down at its worst. GSK is now higher than it was immediately before the downturn, whereas the FTSE 100 is still well down. | aimtoretire | |
17/4/2020 16:07 | Profit taking big time | abdullla | |
17/4/2020 10:16 | I didnt expect GSK to crash as much as the rest of the market last month, thought it would offer a bit of protection, especially since the crisis being of a 'medical' nature. Anyhow, seems to be recovering quite a bit now ... | mister md |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions